Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Amgen Inc. - Amgen Receives Executive Summary from Independent Cochrane Collaboration Review of ESAs in Oncology
Antigenics Inc. - FDA Grants Permission for Export of Antigenics' Oncophage to Russia
Anxiety Disorders - Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
Applied Biosystems Inc. - Applied Biosystems Receives FDA 510k Clearance for Real-time PCR Instrument for Use with New Flu Test from U.S. Centers for Disease Control and Prevention
Applied Biosystems Inc. - U.S. Food and Drug Administration Selects Applied Biosystems to Provide Mass Spectrometry Instrument Systems for Food Contaminant Testing
Artes Medical, Inc. - Artes Medical Completes $2.4 Million Private Placement
Biologics - Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy
Biomedicine - Verax Biomedical Platelet PGD(R) Test for Bacterial Detection Now CE Marked
Bioniche Pharma - Bioniche Pharma Receives FDA Approval for 10 mg/mL Strength of Ketamine Hydrochloride Injection, USP
Biopharmaceuticals - ARCA biopharma to Present at JMP Securities Healthcare Focus Conference
Bristol-Myers Squibb Company - U.S. Food & Drug Administration Approved the use of REYATAZ atazanavir sulfate Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
Bronchiectasis - ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia
CIGNA - CIGNA Expands Reporting of Its Quality Scores as Part of Efforts to Improve the U.S. Health Care System
Clinical Trial Research - Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
Contraception - PAHEF Partners with Other Organizations on Teen Pregnancy Prevention
Cyberonics, Inc. - Cyberonics Provides Update on Depression Indication
Cystic Fibrosis - Transave, Inc. Secures $12.5 Million in New Financing
deCODE genetics - deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders
Drug Development - FDA Continues to Review Prasugrel New Drug Application
Drug Development - NeoVista Unveils 18-month Data on Novel Wet AMD Therapy at Retina Society Meeting
Drug Resistance - Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
Emergent BioSolutions Inc. - Emergent BioSolutions Signs Contract with BARDA/NIAID, Valued at Up to $29.7 Million, to Fund Development of AV7909 - a Next Generation Anthrax Vaccine
Emergent BioSolutions Inc. - U.S. Government to Purchase Additional 14.5 Million Doses of BioThrax under New Contract Valued at up to $404 Million
Endometrial Cancer - Rhode Island Hospital First in the World to Treat Endometrial Cancer With New Form of Electronic Brachytherapy
Genentech, Inc. - Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
Haemacure Corporation - Haemacure Appoints Thomas J. Lynch, J.D., Ph.D. to Board of Directors
Headache and Migraine - TorreyPines Therapeutics Reports Successful End-of-Phase II Meeting With FDA for Tezampanel
Heart Bypass Surgery - Cardica's Anastomosis Systems Enable 'Total Connector' Beating Heart Cardiac Bypass Procedures
HumanTouch, Llc - HumanTouch, LLC is Selected for $2.5 Billion Contract Providing Information Technology Services and Solutions for the U.S. Food and Drug Administration
Image Solutions, Inc. - ISI Reaches Major Milestone, Filing its 1,000th eCTD Submission
Influenza - APHL Instrumental in Development of New Test for Rapid Detection of Influenza
Lucid, Inc. - Lucid Receives FDA Clearance to Market Its VivaScope Reflective Confocal Microscope System in the U.S.
Medicare and Medicaid - $425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest Biotechnology Medicaid Fraud Case; Qui Tam Whistleblower Attorney Brian P. Kenney, Esq. Filed First Complaint With Client SIN
Medicare and Medicaid - Ohio Sales Rep's Information Launched Massive Government Investigation of Cephalon
Medtronic, Inc. - FDA Classifies Medtronic's Notification Related to Improper Connection of Sutureless Intrathecal Catheters as a Class I Recall
Non-Small Cell Lung Cancer - FDA Grants Lilly's ALIMTA(R) (Pemetrexed for Injection) Third U.S. Approval
Nuance Communications, Inc. - Nuance Acquires Philips Speech Recognition Systems, Expands European Healthcare Business
Osteoporosis - New FDA Health Claim Provides Another Reason to Enjoy Three Daily Servings of Dairy
Osteoporosis - Vitamin D Added to FDA Osteoporosis Risk-Reduction Health Claim
PBM Holdings, Inc. - Canadian Brand-Name Infant Formulas No Better than Private-Label Formulas
Pharmaceutical Care Management Association - New PCMA Research: State Legislative Proposals Restricting Access to Generic Medicines Would Increase Costs $29 Billion Over 10 Years
Pneumonia - Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
Pneumonia - Advanced Life Sciences Announces NDA Submission for Cethromycin in Community Acquired Pneumonia
pSivida Corp. - pSivida Release: Results from the Six-Month Interim Readout of the Human PK Iluvien Study
Psoriasis - Synvista Therapeutics Receives Approval to Begin Phase 2 Trial of Topical SYI-2074 in Psoriasis
